On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...